Janux Therapeutics (JANX) Enterprise Value (2020 - 2026)
Janux Therapeutics (JANX) reported Enterprise Value of -$956.4 million for Q1 2026, up 5.7% year-over-year from -$904.9 million in Q1 2025, and up 1.05% quarter-over-quarter from -$966.6 million in Q4 2025.
Janux Therapeutics (JANX) Enterprise Value (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 7 years of Enterprise Value data on file, last reported at -$956.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$956.4 million, up 5.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$956.4 million (up 5.7% YoY), and the FY2025 annual result was -$966.6 million, up 5.72% from the prior year.
- Enterprise Value grew to -$956.4 million in Q1 2026 per JANX's latest filing, from -$966.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$303.3 million in Q2 2023 and troughed at -$1.0 billion in Q4 2024.
- A 5-year average of -$623.4 million and a median of -$646.3 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 51.34% in 2022, then plunged 197.99% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$327.0 million in 2022, then slipped by 5.2% to -$344.0 million in 2023, then sank by 197.99% to -$1.0 billion in 2024, then increased by 5.72% to -$966.6 million in 2025, then increased by 1.05% to -$956.4 million in 2026.
- Business Quant data shows JANX's Enterprise Value at -$956.4 million in Q1 2026, -$966.6 million in Q4 2025, and -$989.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - | -956.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -956.39 Mn |
| Dec 31, 2025 | -966.57 Mn |
| Sep 30, 2025 | -988.99 Mn |
| Jun 30, 2025 | -996.01 Mn |
| Mar 31, 2025 | -1.01 Bn |
| Dec 31, 2024 | -1.03 Bn |
| Sep 30, 2024 | -658.03 Mn |
| Jun 30, 2024 | -646.29 Mn |
| Mar 31, 2024 | -651.76 Mn |
| Dec 31, 2023 | -344.03 Mn |
| Sep 30, 2023 | -349.71 Mn |
| Jun 30, 2023 | -303.29 Mn |
| Mar 31, 2023 | -316.88 Mn |
| Dec 31, 2022 | -327.02 Mn |
| Sep 30, 2022 | -338.76 Mn |
| Jun 30, 2022 | -354.30 Mn |
| Mar 31, 2022 | -361.20 Mn |
| Dec 31, 2021 | -374.97 Mn |
| Sep 30, 2021 | -696.24 Mn |
| Jun 30, 2021 | -394.20 Mn |